← Back to dashboard
Stryker
Stryker's Mako franchise makes it one of the clearest scaled robotics names in orthopedics.
Metric timing
This page mixes live market data, trailing fundamentals, and latest reported statement data.
Live / market snapshot
Price, 1D change, market cap, and enterprise value are current market-based figures.
TTM / forward
Most valuation and margin cards are trailing twelve months, while forward P/E uses forward consensus.
Latest quarter / dividend cadence
Balance-sheet ratios use the latest reported quarter. Dividend cadence is inferred from recent payout history.
latest annual revenue
latest quarterly revenue
latest annual profit
latest quarterly profit
annualized per share
latest ex-dividend cash amount
Latest headlines
Recent company headlines. Each link opens the original article in a new tab.
Microsoft Security Concerns Rise After Cyberattack
U.S. flags risks in widely used enterprise tools
Stryker Investors Weigh Cyberattack Recovery As CEO Joins GE HealthCare BoardStryker CEO Kevin Lobo has been appointed to the Board of Directors of GE HealthCare. The appointment links leadership at two large medical technology companies with global reach. Stryker, traded as NYSE:SYK, enters this leadership development with its shares at $345.81. Over the past 3 years the stock shows a total return of 30.7%, and over 5 years a total return of 55.7%, which gives investors some historical context for how the company has rewarded long term holders. For investors...
1 Oversold Stock Primed to Rebound and 2 We QuestionRock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?
Healthcare Stocks Are Trading at a Deep Discount. Eli Lilly and Others Are Worth a Look.Investors have ignored healthcare as they have tried to capture earnings momentum in AI-related semiconductor stocks.
Here's Why You Should Hold Stryker Stock in Your Portfolio for NowStryker rides on double-digit growth and robotics demand into 2026, but tariffs, vascular weakness and international hurdles cloud its near-term outlook.
Microsoft Tests Key Level After MedTech Cyberattack Incident; Is The Stock A Buy Now?Microsoft stock is lingering near the 400 level after reports of a cyberattack on Stryker's systems involving Microsoft's applications.
Why it could benefit going forward
- Stryker's Mako franchise makes it one of the clearest scaled robotics names in orthopedics.
- Recent expansion into handheld robotics broadens the Mako platform and gives the sleeve another real medical-robotics leader.
- It adds exposure to hospital robotics without relying on the exact same thesis as Intuitive.
Moat / edge
- Established Mako installed base and surgeon workflow integration.
- Strong orthopedic distribution and clinical relationships.
- A robotics platform that can expand across procedures over time.
What to watch
- Mako placements and utilization.
- Adoption of new handheld robotics offerings.
- How much robotics continues to differentiate Stryker in orthopedics.
Key risks
- Hospital budgets and elective procedure trends can affect demand.
- The robotics narrative is important, but it still sits inside a broader medtech company.
Business snapshot
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.